Star Combo Pharma (S66.AX) Stock Price
Star Combo Pharma Price
Revenue has compounded at 13.7% per year over the past 12 years to 23.57 M AUD. Earnings per share have declined at 0.3% per year over the last 12 years. Star Combo Pharma's net margin stands at 1.7%, up from -3.0% several years earlier. Star Combo Pharma currently offers a dividend yield of about 3.53%. The payout ratio is around 52% of earnings. The dividend has grown at 0.0% per year over the past 2 years.
Star Combo Pharma stock price
Star Combo Pharma business model & stock analysis
Frequently asked questions about Star Combo Pharma
Converted at the current exchange rate, the Star Combo Pharma share trades at 0.09 EUR (0.14 AUD).
The Star Combo Pharma share (S66.AX) is listed on 1 stock exchanges, including: ASX (S66.AX).
The revenue of Star Combo Pharma is 23.57 M AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Star Combo Pharma is 394,606.00 AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Star Combo Pharma is currently 47.93. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Star Combo Pharma stock.
The price-to-sales ratio (P/S) of Star Combo Pharma is currently 0.80. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Star Combo Pharma stock.
The Eulerpool Quality Score for Star Combo Pharma is 2/10.
The ISIN of Star Combo Pharma is AU0000004798. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Star Combo Pharma is S66.AX. The ticker symbol is used to trade Star Combo Pharma shares on the stock exchange.
Star Combo Pharma stock
Star Combo Pharma Peer Group
Star Combo Pharma Ticker
Star Combo Pharma FIGI
All fundamentals and in-depth analysis of Star Combo Pharma
Our stock analysis for Star Combo Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Star Combo Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.